Oakstone Update in Urologic Oncology

Format:  videos + pdf
Release Year : 2026

Overview

Oakstone Update in Urologic Oncology is a comprehensive program designed to provide healthcare professionals with the latest evidence-based advances in the diagnosis, treatment, and multidisciplinary management of genitourinary (GU) cancers. This course delivers an in-depth review of current clinical guidelines, emerging research, advanced diagnostic techniques, and evolving therapeutic strategies to support high-quality patient care.

Covering the full spectrum of GU oncology, the program integrates recent clinical trial data, precision medicine, genomic testing, advanced imaging, immunotherapy, and survivorship principles. Participants will gain practical knowledge that can be applied immediately in clinical practice while preparing for board examinations or maintaining certification.

Date of Original Release: May 31, 2026

---

Learning Objectives

After completing this course, participants will be able to:

• Interpret the latest clinical guidelines and pivotal trial data for localized and advanced genitourinary malignancies.
• Integrate imaging, genomic, molecular, and biomarker information into personalized diagnostic and treatment strategies.
• Develop multidisciplinary treatment plans incorporating surgery, systemic therapy, radiation therapy, and survivorship care.
• Apply evidence-based approaches to improve coordination of care and patient outcomes.
• Evaluate emerging therapies, clinical research, and evolving standards of care in urologic oncology.

---

Course Topics

Foundations of Genitourinary Oncology

• Global epidemiology and disease burden
• Clinical trial design and interpretation
• Artificial intelligence applications in GU cancers
• Frailty assessment in oncology patients
• Enhanced recovery after surgery
• Smoking cessation in genitourinary cancer care
• Palliative and end-of-life care
• Diagnosis and management of benign and malignant adrenal lesions

Prostate Cancer

• Contemporary PSA screening strategies
• Prostate biopsy techniques and emerging approaches
• Genomic classifiers for screening and risk assessment
• Risk stratification and personalized treatment planning
• Active surveillance
• Robotic-assisted radical prostatectomy
• Radiation therapy for localized, intermediate-risk, high-risk, and locally advanced disease
• Focal therapy
• Oligometastatic disease and biochemical recurrence
• Management of advanced prostate cancer
• Survivorship, sexual health, urinary continence, and treatment-related adverse effects

Bladder Cancer

• Evaluation of microscopic and gross hematuria
• Diagnosis and risk stratification of non-muscle-invasive bladder cancer
• Treatment strategies for non-muscle-invasive bladder cancer
• Neoadjuvant and adjuvant therapies
• Radical cystectomy and urinary diversion
• Bladder preservation protocols
• Upper tract urothelial carcinoma diagnosis and management
• Women's sexual health following radical cystectomy

Kidney Cancer

• Advanced imaging for renal mass evaluation
• Management of small renal masses
• Open and robotic surgical approaches
• Advanced renal cell carcinoma
• Radiation therapy in renal cell carcinoma
• Contemporary systemic therapies
• Non-clear-cell renal tumors and hereditary syndromes

Testicular Cancer

• Management of early-stage germ-cell tumors
• Treatment strategies for metastatic germ-cell cancers

Penile Cancer

• Management of organ-confined disease
• Treatment of advanced penile cancer

Pediatric Urologic Oncology

• Principles of pediatric genitourinary cancer management

Surgical Innovation

• Optimizing performance and efficiency in robotic-assisted procedures

---

Key Features

• Comprehensive review of the latest developments in urologic oncology.
• Evidence-based content aligned with current clinical practice guidelines.
• Coverage of localized, advanced, and metastatic genitourinary cancers.
• Focus on precision medicine, biomarkers, genomic testing, and advanced imaging.
• Practical guidance for multidisciplinary care coordination.
• Expert discussion of immunotherapy, targeted therapy, radiation therapy, and surgical management.
• Emphasis on survivorship, quality of life, and patient-centered care.

---

Intended Audience

This program is designed for:

• Urologists
• Urologic Oncologists
• Medical Oncologists
• Radiation Oncologists
• Surgical Oncologists
• Oncology Fellows and Residents
• Advanced Practice Providers
• Physician Assistants
• Nurse Practitioners
• Oncology Nurses
• Healthcare professionals involved in the diagnosis and management of genitourinary cancers

---

Why Choose This Course?

Oakstone Update in Urologic Oncology provides a comprehensive review of the rapidly evolving field of genitourinary cancer care. By combining current clinical guidelines, landmark research, multidisciplinary treatment strategies, and practical case-based education, this program equips clinicians with the knowledge needed to optimize diagnosis